These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 12868191)

  • 1. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
    Tkaczyk M; Owczarek D; Finke D; Nowicki M
    Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increased thrombin-genesis in cyclosporine A-treated idiopathic nephrotic syndrome in children].
    Tkaczyk M; Owczarek D; Nowicki M
    Pol Merkur Lekarski; 2003 Feb; 14(80):106-9. PubMed ID: 12728666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E
    Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oxidative potential of neutrophils in cyclosporine A treated children with idiopathic nephrotic syndrome].
    Tkaczyk M; Lewkowicz P; Nowicki M; Tchórzewski H; Baj Z
    Pol Merkur Lekarski; 2004 Oct; 17(100):331-4. PubMed ID: 15690694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface markers of platelet function in idiopathic nephrotic syndrome in children.
    Tkaczyk M; Baj Z
    Pediatr Nephrol; 2002 Aug; 17(8):673-7. PubMed ID: 12185480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
    Meyrier A
    J Nephrol; 1997; 10(1):14-24. PubMed ID: 9241620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome.
    Tkaczyk M; Czupryniak A; Owczarek D; Lukamowicz J; Nowicki M
    Am J Nephrol; 2008; 28(2):197-202. PubMed ID: 17962717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A.
    Wasilewska A; Zoch-Zwierz W; Tenderenda E
    Acta Paediatr; 2006 Mar; 95(3):291-6. PubMed ID: 16497638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine utilization in idiopathic nephrotic syndrome in children.
    Saeed B; Ossman MI; Sheriff S
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):497-502. PubMed ID: 17186683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
    Mehta P; Parker RI
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
    Griveas I; Visvardis G; Papadopoulou D; Nakopolou L; Karanikas E; Gogos K; Stavianoudakis G
    Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activation of coagulation cascade in children during an idiopathic nephrotic syndrome relapse].
    Tkaczyk M; Owczarek D; Puczko-Nogal B; Makosiej R; Rogowska-Kalisz A; Ptaśnik W; Finke D
    Pol Merkur Lekarski; 2000 Apr; 8(46):226-7. PubMed ID: 10897622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A does not affect platelets in children with idiopathic nephrotic syndrome.
    Tkaczyk M; Baj Z; Nowicki M
    Pediatr Nephrol; 2005 Jan; 20(1):30-5. PubMed ID: 15517412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in children with ulcerative colitis].
    Grabarczyk E; Szaflarska-Popławska A; Góralczyk K; Rość D
    Pol Merkur Lekarski; 2006 Mar; 20(117):326-8. PubMed ID: 16780267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children].
    Wyszyńska T; Ksiazek J; Wieteska-Klimczak A; Gorzkowska-Paczwa M; Dorywalski T; Tysarowska A
    Pol Merkur Lekarski; 2001 Aug; 11(62):140-3. PubMed ID: 11757213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet activation in relapse idiopathic nephrotic syndrome in children].
    Tkaczyk M; Baj Z; Nowicki M
    Pol Merkur Lekarski; 2001 Apr; 10(58):229-32. PubMed ID: 11434163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.